Celine Halioua

I'm Celine, founder and CEO of Loyal, where we're developing drugs to extend the healthy lifespan of dogs. I dropped out of a DPhil at Oxford to build this because the biology of aging matters more in practice than in theory.

Before Loyal, I was Chief of Staff at The Longevity Fund and worked in neuro-oncology at Sanford Burnham Prebys. I care about healthcare inequality, the economics of novel therapeutics, and what happens when you actually try to bring aging biology to market.

Ask me about longevity science, building a biotech company, and our open roles.